← All companiesPPalvella Therapeutics, Inc.
PVLA
Palvella Therapeutics, Inc. net income by year
Palvella Therapeutics, Inc. (PVLA) reported net income of -$41.72M for fiscal year 2025, as filed in its audited annual report with the SEC.
PVLA annual net income
PVLA net income 2013-2025
| Fiscal year | Net Income | Change |
|---|
| FY 2025 | -$41.72M | -139.3% |
| FY 2024 | -$17.43M | -193.3% |
| FY 2023 | $18.69M | +156.2% |
| FY 2022 | -$33.28M | +27.2% |
| FY 2021 | -$45.74M | -22.9% |
| FY 2020 | -$37.23M | -46.2% |
| FY 2019 | -$25.47M | +4.8% |
| FY 2018 | -$26.75M | -51.6% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does Palvella Therapeutics, Inc. make?
Palvella Therapeutics, Inc. (PVLA) reported net income of -$41.72M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Palvella Therapeutics, Inc.'s net income changed over time?
Between fiscal 2013 and fiscal 2025, Palvella Therapeutics, Inc.'s net income declined from $66.20K to -$41.72M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.